{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:37:14Z","timestamp":1787009834229,"version":"build-2736575974"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,7]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>Trigeminal neuralgia (TN) is commonly seen in older persons and negatively influences their daily life. Although some research on the efficacy of TN drugs has been conducted, the optimal choice still remains uncertain. Therefore, this network meta-analysis (NMA) evaluated the efficacy and performance of 8 drugs with respect to TN.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>All literature was retrieved from the PubMed and Embase electronic databases by jointly searching key terms. The only outcome was response rate, expressed as the odds ratio with 95% credible\/confidence intervals. Both a pairwise meta-analysis and NMA were conducted. Heat plot and node splitting were computed to measure the consistency between direct and indirect evidence. In addition, surface under cumulative ranking curves were utilized to rank different drugs for treating TN.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>In total, 13 studies and 672 TN patients were included in this NMA. With regard to the primary endpoint response rate, only lidocaine (LDC), botulinum toxin type A (BTX-A), and carbamazepine (CBZ) had a statistical better performance than the placebo. According to the surface under cumulative ranking curves, LDC, BTX-A, and CBZ are the most effective drugs for treating patients with TN.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Among the 8 drugs investigated, all exhibited a capacity to alleviate TN more than the placebo except for pimozide and proparacaine. Moreover, LDC, BTX-A, and CBZ stood out for their high efficacy and could be recommended as the primary choice of treatment for TN.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ajp.0000000000000577","type":"journal-article","created":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T19:02:56Z","timestamp":1512154976000},"page":"685-690","source":"Crossref","is-referenced-by-count":16,"title":["Efficacy of 8 Different Drug Treatments for Patients With Trigeminal Neuralgia"],"prefix":"10.1097","volume":"34","author":[{"given":"Fang","family":"Yang","sequence":"first","affiliation":[{"name":"Neurology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Lin","sequence":"additional","affiliation":[{"name":"Traditional Chinese Medicine, People\u2019s Hospital of Rizhao, Rizhao"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihua","family":"Dong","sequence":"additional","affiliation":[{"name":"Neurology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Magnetic Resonance Imaging, People\u2019s Hospital of Zhangqiu District, Zhangqiu"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su\u2019e","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Anaesthesiology, People\u2019s Hospital of Weifang, Weifang, Shandong Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230827","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1177\/0333102412441721","article-title":"Botulinum toxin type A for the treatment of trigeminal neuralgia: results from a randomized, double-blind, placebo-controlled trial","volume":"32","author":"Wu","year":"2012","journal-title":"Cephalalgia"},{"key":"R2-20230827","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/pme.12349","article-title":"Immediate analgesic effect of 8% lidocaine applied to the oral mucosa in patients with trigeminal neuralgia","volume":"15","author":"Niki","year":"2014","journal-title":"Pain Med (Malden, Mass)"},{"key":"R3-20230827","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1129-2377-15-34","article-title":"Natural history and outcome of 200 outpatients with classical trigeminal neuralgia treated with carbamazepine or oxcarbazepine in a tertiary centre for neuropathic pain","volume":"15","author":"Di Stefano","year":"2014","journal-title":"J Headache Pain"},{"key":"R4-20230827","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jcma.2011.04.002","article-title":"Lamotrigine for trigeminal neuralgia: efficacy and safety in comparison with carbamazepine","volume":"74","author":"Shaikh","year":"2011","journal-title":"J Chin Med Assoc"},{"key":"R5-20230827","first-page":"CD007312","article-title":"Neurosurgical interventions for the treatment of classical trigeminal neuralgia","volume":"9","author":"Zakrzewska","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"R6-20230827","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/j.1468-1331.2008.02185.x","article-title":"AAN-EFNS guidelines on trigeminal neuralgia management","volume":"15","author":"Cruccu","year":"2008","journal-title":"Eur J Neurol"},{"key":"R7-20230827","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1001\/archneur.1989.00520450030015","article-title":"Pimozide therapy for trigeminal neuralgia","volume":"46","author":"Lechin","year":"1989","journal-title":"Arch Neurol"},{"key":"R8-20230827","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1129-2377-15-65","article-title":"Two doses of botulinum toxin type A for the treatment of trigeminal neuralgia: observation of therapeutic effect from a randomized, double-blind, placebo-controlled trial","volume":"15","author":"Zhang","year":"2014","journal-title":"J Headache Pain"},{"key":"R9-20230827","first-page":"CD004029","article-title":"Non-antiepileptic drugs for trigeminal neuralgia","volume":"12","author":"Zhang","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"R10-20230827","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/02688690701219175","article-title":"Evidence-based approach to the medical management of trigeminal neuralgia","volume":"21","author":"Jorns","year":"2007","journal-title":"Br J Neurosurg"},{"key":"R11-20230827","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1526-4610.1969.hed0901064.x","article-title":"A long-term low-dosage study of carbamazepine in trigeminal neuralgia","volume":"9","author":"Lloyd-Smith","year":"1969","journal-title":"Headache"},{"key":"R12-20230827","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1526-4610.1969.hed0901054.x","article-title":"A four year double-blind study of tegretol in facial pain","volume":"9","author":"Nicol","year":"1969","journal-title":"Headache"},{"key":"R13-20230827","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1046\/j.1468-2982.1986.0603181.x","article-title":"Tizanidine in the management of trigeminal neuralgia","volume":"6","author":"Vilming","year":"1986","journal-title":"Cephalalgia"},{"key":"R14-20230827","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0304-3959(93)90222-B","article-title":"A clinical and experimental investigation of the effects of tizanidine in trigeminal neuralgia","volume":"53","author":"Fromm","year":"1993","journal-title":"Pain"},{"key":"R15-20230827","doi-asserted-by":"crossref","first-page":"993","DOI":"10.3171\/jns.1994.80.6.0993","article-title":"The effect of single-application topical ophthalmic anesthesia in patients with trigeminal neuralgia. A randomized double-blind placebo-controlled trial","volume":"80","author":"Kondziolka","year":"1994","journal-title":"J Neurosurg"},{"key":"R16-20230827","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0304-3959(97)00104-8","article-title":"Lamotrigine (lamictal) in refractory trigeminal neuralgia: results from a double-blind placebo controlled crossover trial","volume":"73","author":"Zakrzewska","year":"1997","journal-title":"Pain"},{"key":"R17-20230827","first-page":"461","article-title":"Oxcarbazepine in the treatment of idiopathic trigeminal neuralgia","volume":"20","author":"Liebel","year":"2001","journal-title":"Nervenheilkunde"},{"key":"R19-20230827","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/j.1468-2982.2008.01800.x","article-title":"Neuropsychiatric side-effects of lidocaine: examples from the treatment of headache and a review","volume":"29","author":"Gil-Gouveia","year":"2009","journal-title":"Cephalalgia"},{"key":"R20-20230827","first-page":"460","article-title":"Local anesthetic lidocaine inhibits the effect of granulocyte colony-stimulating factor on human neutrophil functions","volume":"22","author":"Ohsaka","year":"1994","journal-title":"Exp Hematol"},{"key":"R21-20230827","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.coph.2004.12.006","article-title":"Botulinal neurotoxins: revival of an old killer","volume":"5","author":"Montecucco","year":"2005","journal-title":"Curr Opin Pharmacol"},{"key":"R22-20230827","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jaad.2005.06.011","article-title":"Botulinum toxin type A injections: adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases","volume":"53","author":"Cote","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"R23-20230827","first-page":"CD007124","article-title":"Immediate-release versus controlled-release carbamazepine in the treatment of epilepsy","volume":"2","author":"Powell","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"R24-20230827","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.seizure.2013.03.016","article-title":"Neurological adverse events of new generation sodium blocker antiepileptic drugs. Meta-analysis of randomized, double-blinded studies with eslicarbazepine acetate, lacosamide and oxcarbazepine","volume":"22","author":"Zaccara","year":"2013","journal-title":"Seizure"},{"key":"R25-20230827","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/j.1468-1331.2010.02999.x","article-title":"EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision","volume":"17","author":"Attal","year":"2010","journal-title":"Eur J Neurol"}],"container-title":["The Clinical Journal of Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00002508-201807000-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,27]],"date-time":"2023-08-27T01:26:30Z","timestamp":1693099590000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002508-201807000-00012"}},"subtitle":["A Network Meta-analysis"],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":24,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/ajp.0000000000000577","relation":{},"ISSN":["0749-8047"],"issn-type":[{"value":"0749-8047","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]}}}